Success Metrics

Clinical Success Rate
93.1%

Based on 27 completed trials

Completion Rate
93%(27/29)
Active Trials
2(5%)
Results Posted
15%(4 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_2
11
29%
Ph phase_3
4
11%
Ph phase_4
7
18%
Ph not_applicable
11
29%
Ph phase_1
3
8%

Phase Distribution

3

Early Stage

11

Mid Stage

11

Late Stage

Phase Distribution36 total trials
Phase 1Safety & dosage
3(8.3%)
Phase 2Efficacy & side effects
11(30.6%)
Phase 3Large-scale testing
4(11.1%)
Phase 4Post-market surveillance
7(19.4%)
N/ANon-phased studies
11(30.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.1%

27 of 29 finished

Non-Completion Rate

6.9%

2 ended early

Currently Active

2

trials recruiting

Total Trials

38

all time

Status Distribution
Active(4)
Completed(27)
Terminated(2)
Other(5)

Detailed Status

Completed27
unknown5
Terminated2
Recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
38
Active
2
Success Rate
93.1%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (8.3%)
Phase 211 (30.6%)
Phase 34 (11.1%)
Phase 47 (19.4%)
N/A11 (30.6%)

Trials by Status

terminated25%
recruiting25%
unknown513%
completed2771%
not_yet_recruiting25%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT01162109Phase 1

Zinc Therapy in Critical Illness

Completed
NCT07383363Not Applicable

Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy

Completed
NCT06517862Phase 4

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

Recruiting
NCT06561061Phase 2

Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2)

Completed
NCT07275827Phase 3

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

Not Yet Recruiting
NCT07102836Phase 2

COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

Recruiting
NCT06482034Phase 2

Effect of N-acetyl Cysteine and Zinc in Management of Head and Neck Cancer Radiotherapy Induced Oral Mucositis

Completed
NCT06556511Not Applicable

Efficacy Of Zinc Towards The Outcome on Children With Sepsis

Completed
NCT06433674Phase 3

Enteral Zinc Supplementation in Very Low Birth Weight Infants

Not Yet Recruiting
NCT03404310Not Applicable

Zinc Sulfate for Human Papillomavirus (HPV)

Terminated
NCT05311540Phase 4

Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial

Completed
NCT05161611Not Applicable

Effect of Oral Zinc Sulfate on Jaundice in Neonates Admitted to Neonatal Intensive Care Unit

Completed
NCT05395143Phase 2

Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients

Unknown
NCT01809132Phase 2

Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis

Completed
NCT01229579Not Applicable

Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan

Completed
NCT04301336Phase 2

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

Completed
NCT04370782Phase 4

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Completed
NCT01062009Phase 1

Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children

Completed
NCT04061538Not Applicable

Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age

Completed
NCT04050488Phase 4

Zinc Supplementation on Very Low Birth Weight Infant

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
38